For example, in colorectal cancer, EPHB2 often exhibits a tumor-suppressive role, and its inactivation correlates with tumor progression and invasion; whereas in prostate cancer, EPHB2 may promote tumor growth and metastasis [21–23]. This evidence concerns the gene EPHB2 and neoplasm.